Library / regulatory-reference
Pakistan: Drug Regulatory Authority of Pakistan (DRAP)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Drug Regulatory Authority of Pakistan is the country's national regulator for medicines, biological products, medical devices, cosmetics and traditional remedies, established as an autonomous body under the federal health ministry to unify oversight that had been fragmented across provinces.
Pakistan has one of the larger pharmaceutical markets in Asia with a substantial domestic manufacturing sector, and the authority's registration and inspection decisions shape supply across the country and into export markets.
How products enter the market
Medicines require registration before marketing, following evaluation of quality, safety and efficacy, with registration boards deciding applications and pricing handled through a linked governmental process. The authority has been digitizing registration and licensing workflows to manage a large application backlog inherited at its creation.
Medical devices are registered under a dedicated framework introduced in recent years, and the authority licenses manufacturers, importers and distributors and inspects production sites for good-manufacturing-practice compliance.
Regional and international role
The authority participates in international regulatory cooperation and has been working toward international maturity benchmarks, with particular focus on its vaccine and biological-product oversight given domestic production.
Pakistan's export-oriented generic sector means the authority's manufacturing inspections carry weight with importing regulators across Asia, Africa and the Middle East.
Using this profile
The authority publishes registers, guidance and public notices in English through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: the authority illustrates the consolidating regulator managing a large manufacturing base: unifying previously provincial oversight, digitizing registration, and building device regulation from a standing start.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.